Peak bone mass in patients with phenylketonuria

Journal of Inherited Metabolic Disease

Volumn 30, Issue 2, 2007, Pages 202-208

  Modan Moses, D ^a,d   Vered, I ^b   Schwartz, G ^c,d   Anikster, Y ^c,d   Abraham, S ^c   Segev, R ^c   Efrati, Ori ^c,d  

^a Safra Children's Hospital   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c Edmond and Lily Safra Children's Hospital   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; MINERAL; PHENYLALANINE; PROTEIN; TRACE ELEMENT; VITAMIN D;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BODY FAT; BODY MASS; BONE DENSITY; BONE MASS; BONE TURNOVER; CALCIUM DEFICIENCY; CALCIUM INTAKE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; HYPOTHESIS; MALE; MEDICAL DOCUMENTATION; NUTRITIONAL DEFICIENCY; NUTRITIONAL PARAMETERS; OSTEOPENIA; OSTEOPOROSIS; PATIENT COMPLIANCE; PHENYLKETONURIA; PROTEIN DEFICIENCY; PROTEIN INTAKE; VITAMIN D DEFICIENCY;

ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; COHORT STUDIES; FEMALE; HORMONES; HUMANS; INCIDENCE; MALE; NUTRITIONAL STATUS; OSMOLAR CONCENTRATION; OSTEOPOROSIS; PATIENT COMPLIANCE; PHENYLALANINE; PHENYLKETONURIAS;

EID: 33947635001     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0462-9     Document Type: Article

References (38)

1. Aasen G, Fagertun H, Halse J (2006). Body composition analysis by dual X-ray absorptiometry: In vivo and in vitro comparison of three different fan-beam instruments. Scand J Clin Lab Invest 66: 659-666.
2. Albertazzi P, Coupland K (2002) Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas 42: 13-22.
3. Allen JR, Humphries IR, Waters DL, et al (1994) Related Decreased bone mineral density in children with phenylketonuria. Am J Clin Nutr 59: 419-422.
4. Al-Qadreh A, Schulpis KH, Athanasopoulou H, Mengreli C, Skarpalezou A, Voskaki I (1998) Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr 87: 1162-1166.
5. 12 deficiency in an adult phenylketonuric patient. J Inherit Metab Dis 20: 603-604.
6. Barat P, Barthe N, Redonnet-Vernhet I, Parrot F (2002) The impact of the control of serum phenylalanine levels on osteopenia in patients with phenylketonuria. Eur J Pediatr 161: 687-688.
7. 12 deficiency. Acta Psychiatr Scand 108: 156-159.
8. Burgard P, Bremer HJ, Buhrdel P, et al (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr 158: 46-54.
9. Carson DJ, Greeves LG, Sweeney LE, Crone MD (1990) Osteopenia and phenylketonuria. Pediatr Radiol 20: 598-599.
10. Clark BJ (1992) After a positive Guthrie - what next? Dietary management for the child with phenylketonuria. Eur J Clin Nutr 46(Suppl 1): S33-339.
11. Cohen BE, Szeinberg A, Levine Y, et al (1978) Phenylketonuria (PKU) in Israel. Monogr Hum Genet 9: 95-101.
12. Compston J (2006) Bone quality: What is it and how is it measured? Arq Bras Endocrinol Metabol. 50: 579-585.
13. Fisch RO, Matalon R, Weisberg S, Michals K (1997) Phenylketonuria: current dietary treatment practices in the United States and Canada. J Am Coll Nutr 16: 147-151.
14. Genant HK, Cooper C, Poor G, et al (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10: 259-264.
15. Greeves LG, Carson DJ, Magee A, Patterson C (1997) Fractures and phenylketonuria. Acta Paediatr 86: 242-244.
16. Guthrie R, Susi A (1963) A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32: 338-343.
17. 12 deficiency in adolescents and young adults with phenylketonuria. Eur J Pediatr 155(Suppl 1): S145-147.
18. Hellekson KL: National Institutes of Health (2001) NIH consensus statement on phenylketonuria. Am Fam Physician 63: 1430-1432.
19. Hillman L, Schlotzhauer C, Lee D, et al (1996) Decreased bone mineralization in children with phenylketonuria under treatment. Eur J Pediatr 155(Suppl 1): S148-152.
20. Institute of Medicine (1997) Dietary reference intakes for calcium, magnesium, phosphorus, vitamin D, and fluoride. Washington, DC: National Academy Press.
21. Kahler SG, Fahey MC (2003) Metabolic disorders and mental retardation. Am J Med Genet 117: 31-41.
22. Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. Osteoporos Int 4: 368-381.
23. Kerstetter JE, Mitnick ME, Gundberg CM, et al (1999) Changes in bone turnover in young women consuming different levels of dietary protein. J Clin Endocrinol Metab 84: 1052-1055.
24. Leib ES, Lewiecki EM, Binkley N, Hamdy RC; International Society for Clinical Densitometry (2004) Official positions of the International Society for Clinical Densitometry. J Clin Densitom 7: 1-6.
25. McMurry MP, Chan GM, Leonard CO, Ernst SL (1992) Related bone mineral status in children with phenylketonuria - relationship to nutritional intake and phenylalanine control. Am J Clin Nutr 55: 997-1004.
26. Medical Research Council Working Party on Phenylketonuria (1993) Phenylketonuria due to phenylalanine hydroxylase deficiency: An unfolding story. BMJ 306: 115-119.
27. Perez-Dueñas B, Cambra FJ, Vilaseca MA, Lambruschini N, Campistol J, Camacho JA (2002) New approach to osteopenia in phenylketonuric patients. Acta Paediatr 91: 899-904.
28. Przyrembel H, Bremer HJ (2000) Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 159 (Suppl 2): S129-135.
29. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB (1992) Bone gain in young adult women. JAMA 268: 2403-2408.
30. Riggs BL, Melton LJ 3rd (1995) The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17(Suppl 5): 505S-511S.
31. Saperstein DS, Barohn R (2002) Peripheral neuropathy due to cobalamin deficiency. Curr Treat Options Neurol 4: 197-201.
32. Schwahn B, Mokov E, Scheidhauer K, Lettgen B, Schonau E (1998) Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography. Acta Paediatr 87: 61-63.
33. Smith I, Beasley MG, Ades AE (1990) Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 65: 472-478.
34. Smith I, Cook B, Beasley M (1991) Review of neonatal screening programme for phenylketonuria. BMJ 303: 333-335.
35. Teegarden D, Lyle RM, McCabe GP, et al (1998) Dietary calcium, protein, and phosphorus are related to bone mineral density and content in young women. Am J Clin Nutr 68: 749-754.
36. Walter JH, White FJ, Hall SK, et al (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360: 55-57.
37. Woodring JH, Rosenbaum HD (1981) Bone changes in phenylketonuria reassessed. Am J Roentgenol 137: 241-243.
38. Zeman J, Bayer M, Stepan J (1999) Bone mineral density in patients with phenylketonuria. Acta Paediatr 88: 1348-1351.